Skip to content
OpenCapital
Get started

Castle Biosciences CSTL Shares (Diluted)

Shares (Diluted) at other companies

Veracyte logo
VeracyteVCYT
81.3M+1.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
104.2M+19.1%
NeoGenomics logo
NeoGenomicsNEO
129.2M+1.4%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
30.9M+0.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
162.2M+43.1%
GeneDx Holdings logo
GeneDx HoldingsWGS
29.3M+4.2%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S2×+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's shares (diluted)?
Castle Biosciences (CSTL) reported shares (diluted) of 29.9M in Q1 2026.
How has Castle Biosciences's shares (diluted) changed year-over-year?
Castle Biosciences's shares (diluted) increased by 4.5% year-over-year, from 28.6M to 29.9M.
What is the long-term trend for Castle Biosciences's shares (diluted)?
Over 4 years (2021 to 2025), Castle Biosciences's shares (diluted) has grown at a 3.7% compound annual growth rate (CAGR), from 100.4M to 116.2M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.